Analogi GLP-1 s polecane jako leki pierwszego rzutu w przypadku przeciwwskaza do stosowania metforminy
Effects of incretin-based therapy on other obesity-related comorbidities Incretin-based AOM might be beneficial for most of obesity-related comorbidities, notwithstanding their metabolic, load-bearing, and mixed pathogenesis (Fig
The prevalence of anemia during pregnancy and its correlates vary by trimester and hemoglobin assessment method in Eastern Maharashtra, India
Facility charges include operating room time, recovery room, and facility use fees
The post hoc analysis of pooled data from the Semaglutide Treatment Effect in People with Obesity (STEP) 1, 2, 3, and 5 trials indicated that semaglutide treatment at 2.4 mg did not increase the risk of depressive symptoms or suicidal ideation compared to placebo, while demonstrating a statistically significant yet clinically negligible decrease in depressive symptoms [75]